Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Standalone CYAD-01 without preconditioning leads to disease stabilization in three out of 11 metastatic colorectal cancer (mCRC) patients in THINK Phase 1 trialInitial data from first dose cohort of...
-
MCLEAN, Va., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are multifamily...
-
MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care ("POC") diagnostics company focused on infectious diseases, today announced the...
-
Mendes Joins José Avillez, Miguel Laffan, Rui Paula, Henrique Sá Pessoa, Rui Silvestre and Vítor Sobral NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- TAP Air Portugal’s ‘Taste the Stars’ program...
-
New eBook is e-Commerce Holiday Shopping Roadmap for Optimal Customer Experiences BETHESDA, Md., Nov. 09, 2018 (GLOBE NEWSWIRE) -- DMI’s new Black Friday, Cyber Monday & the Future of Commerce...
-
DALLAS, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from multiple cancer indications,...
-
Financing accelerates adoption of VIQ’s AI technology aiAssistTM and software-as-a-service (SaaS) offerings TORONTO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- VIQ Solutions Inc. (“VIQ” or the “Company”)...
-
JACKSONVILLE, Fla., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Stein Mart (NASDAQ: SMRT) announces its biggest giveaway ever valued at $500,000 for this year’s Black Friday Gold Hanger Event. “Our customers...
-
--Well tolerated; dose dependent biological effects consistent with CD40-mediated immune cell activity----Program development expanded based on results observed to date-- HAMPTON, N.J., Nov. 09,...
-
Phase 1a Dose-Escalation Data Demonstrates a Favorable Safety Profile and Signals of Immune Cell Modulation in Patients with Late Stage Solid Tumors REDWOOD CITY, Calif. and WASHINGTON, Nov. 09,...